Brett Sheridan, MD
Thoracic Surgery · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 3 carriers
- Office
- 1
- Since medical school
- 34 years
- Baylor College of Medicine, 1992
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: California Pacific Medical Center- Van Ness Campus. That is not proof they admit you there this week.
Plans that list them
15 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sheridan’s office at (415) 600-5780 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A79567 · Current
Licensed to practise in California · since 2002 · expires 2027-08-31 · Baylor College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Thoracic Surgery - Thoracic and Cardiac Surgery
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$296,125
Medicare paid this office $296,125 for 197 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Replacement of aortic valve through the skin and femoral artery | 76 | $46,665 | $614 |
| Critical care, first 30-74 minutes | 19 | $40,067 | $185 |
| Exploration of chest for bleeding, blood clot, or infection after surgery | 16 | $27,914 | $1,469 |
| New patient visit (60+ min) | 108 | $20,908 | $194 |
| Coronary artery bypass using artery graft, 1 graft | 11 | $14,676 | $1,334 |
See all 13 services
| Replacement of aortic valve through the skin and femoral artery | 76 | $46,665 | $614 |
| Critical care, first 30-74 minutes | 19 | $40,067 | $185 |
| Exploration of chest for bleeding, blood clot, or infection after surgery | 16 | $27,914 | $1,469 |
| New patient visit (60+ min) | 108 | $20,908 | $194 |
| Coronary artery bypass using artery graft, 1 graft | 11 | $14,676 | $1,334 |
| Insertion of external blood flow assist device in lower heart chamber | 11 | $12,013 | $1,001 |
| Evaluation of lower heart chamber assist device | 21 | $8,990 | $34 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $7,639 | $105 |
| Removal of external blood flow assist device in lower heart chamber | 13 | $7,210 | $515 |
| Exposure of underarm or upper chest artery with creation of conduit | 12 | $3,860 | $297 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 34 | $2,467 | $70 |
| Return visit (30+ min) | 17 | $1,913 | $113 |
| Short return visit (20+ min) | 14 | $1,748 | $83 |
Procedures Medicare counted
| Coronary artery bypass graft (CABG) | 13 | More than 50% of doctors who do this |
| Removal of tissue | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Replacement of aortic valve through the skin and femoral artery | 62 | 57 | 64 | 49 | 66 | 76 |
| Exploration of chest for bleeding, blood clot, or infection after surgery | 15 | 18 | 21 | 12 | 17 | 19 |
| Coronary artery bypass using artery graft, 1 graft | – | – | – | 11 | – | 11 |
| Removal of external blood flow assist device in lower heart chamber | – | – | – | – | – | 14 |
| Exposure of underarm or upper chest artery with creation of conduit | – | – | – | – | – | 13 |
| Insertion of external blood flow assist device in lower heart chamber | – | – | – | – | – | 12 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
197 Original Medicare patients in 2024. Average age 76 · Women 37% · Also on Medicaid 23% · Health risk score 1.97. Above the middle of the specialty; the typical thoracic surgery clinician is at 1.74.
Conditions among them: High blood pressure 75% · Coronary heart disease 75% · Heart failure 75% · Chronic kidney disease 47% · Atrial fibrillation 47% · Diabetes 42% · COPD 26% · Depression 19% · Cancer 15% · Stroke 15% · Dementia 10%.
The office billed $1,568,524, Medicare allowed $374,089 and paid $296,125; for 1,037 services of 52 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 197 | 1,037 | 76 | 1.97 | $1,568,524 | $296,125 |
| 2023 | 178 | 748 | 76 | 2.04 | $1,140,781 | $234,853 |
| 2022 | 158 | 559 | 77 | 1.89 | $979,323 | $209,934 |
| 2021 | 189 | 864 | 76 | 1.88 | $1,399,585 | $305,174 |
| 2020 | 137 | 240 | 76 | 2.23 | $633,759 | $151,839 |
| 2019 | 126 | 241 | 75 | 2.24 | $772,356 | $181,384 |
| 2018 | 112 | 214 | 75 | 2.65 | $519,745 | $125,412 |
| 2017 | 66 | 186 | 75 | 2.54 | $557,733 | $124,810 |
| 2016 | 34 | 79 | 70 | 3.33 | $269,487 | $58,132 |
| 2015 | 73 | 215 | 65 | 2.47 | $536,034 | $127,602 |
| 2014 | 68 | 200 | 68 | 2.20 | $467,428 | $105,742 |
| 2013 | 88 | 276 | 67 | 1.84 | $634,022 | $139,181 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Replacement of aortic valve through the skin and femoral artery | 65 | $41,557 | $630 |
| Exploration of chest for bleeding, blood clot, or infection after surgery | 15 | $25,863 | $1,521 |
| Critical care, first 30-74 minutes | 19 | $23,123 | $188 |
| New patient visit (60+ min) | 98 | $19,442 | $198 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $9,607 | $108 |
| Evaluation of lower heart chamber assist device | 20 | $5,057 | $35 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 27 | $2,085 | $74 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,731 | $157 |
2022: 10 services
| Replacement of aortic valve through the skin and femoral artery | 49 | $31,345 | $640 |
| Critical care, first 30-74 minutes | 21 | $22,415 | $192 |
| Exploration of chest for bleeding, blood clot, or infection after surgery | 11 | $20,258 | $1,688 |
| New patient visit (60+ min) | 77 | $15,202 | $197 |
| Coronary artery bypass using artery graft, 1 graft | 11 | $14,691 | $1,336 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $2,944 | $92 |
| Short return visit (20+ min) | 16 | $2,074 | $83 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,929 | $121 |
| Evaluation of lower heart chamber assist device | 16 | $1,756 | $35 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $1,060 | $88 |
2021: 9 services
| Critical care, first 30-74 minutes | 28 | $58,031 | $195 |
| Replacement of aortic valve through the skin and femoral artery | 64 | $41,339 | $646 |
| Exploration of chest for bleeding, blood clot, or infection after surgery | 17 | $32,820 | $1,563 |
| New patient visit (60+ min) | 76 | $15,032 | $198 |
| Evaluation of lower heart chamber assist device | 11 | $4,791 | $35 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,329 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $2,241 | $93 |
| Short return visit (20+ min) | 15 | $1,579 | $88 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,173 | $90 |
2020: 3 services
| Replacement of aortic valve through the skin and femoral artery | 56 | $37,740 | $662 |
| Exploration of chest for bleeding, blood clot, or infection after surgery | 15 | $27,864 | $1,548 |
| New patient visit (45+ min) | 50 | $7,498 | $150 |
2019: 4 services
| Replacement of aortic valve through the skin and femoral artery | 62 | $45,453 | $733 |
| Exploration of chest for bleeding, blood clot, or infection after surgery | 15 | $23,808 | $1,587 |
| Insertion of implanted blood flow assist device in lower heart chamber | 11 | $16,670 | $1,515 |
| New patient visit (45+ min) | 35 | $4,914 | $140 |
2018: 3 services
| Replacement of aortic valve through the skin and femoral artery | 50 | $35,668 | $713 |
| New patient visit (45+ min) | 44 | $6,630 | $151 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,330 | $121 |
2017: 2 services
| Exploration of chest for bleeding, blood clot, or infection after surgery | 11 | $22,041 | $1,574 |
| New patient visit (45+ min) | 23 | $3,491 | $152 |
2016: 1 service
| Insertion of implanted blood flow assist device in lower heart chamber | 12 | $17,213 | $1,434 |
2015: 4 services
| Insertion of implanted blood flow assist device in lower heart chamber | 16 | $21,377 | $1,336 |
| Coronary artery bypass using artery graft, 1 graft | 14 | $19,477 | $1,391 |
| New patient visit (60+ min) | 16 | $2,036 | $127 |
| Harvest of vein using an endoscope | 18 | $222 | $12 |
2014: 4 services
| Coronary artery bypass using artery graft, 1 graft | 14 | $18,111 | $1,294 |
| Insertion of implanted blood flow assist device in lower heart chamber | 11 | $15,165 | $1,379 |
| New patient visit (60+ min) | 19 | $2,196 | $116 |
| Harvest of vein using an endoscope | 14 | $175 | $12 |
2013: 7 services
| Coronary artery bypass using artery graft, 1 graft | 23 | $29,532 | $1,284 |
| Insertion of implanted blood flow assist device in lower heart chamber | 12 | $12,724 | $1,060 |
| New patient visit (60+ min) | 11 | $1,366 | $124 |
| Short return visit (20+ min) | 17 | $699 | $37 |
| Return visit (30+ min) | 11 | $686 | $57 |
| Harvest of vein using an endoscope | 25 | $302 | $12 |
| Therapy procedure using a special bandage and vacuum pump, surface area 50.0 sq cm or less | 12 | $257 | $20 |
Money from drug and device companies
$10,893 in 2025
| 2025 | 6 | 32 | $8,775 | $10,893 |
| 2024 | 3 | 24 | $4,550 | $6,552 |
| 2023 | 3 | 13 | $5,100 | $5,545 |
| 2022 | 4 | 37 | $2,100 | $6,550 |
| 2021 | 4 | 23 | $1,575 | $3,146 |
| 2020 | 3 | 24 | $12,488 | $12,953 |
| 2019 | 8 | 35 | $24,638 | $26,773 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | 2nd Gen Centrimag Primary Console | $9,737 | 11 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $576 | 9 payments
|
| Ethicon US | Prolene | $197 | 4 payments
|
| AtriCure | Atriclip Laa Exclusion System | $176 | 5 payments
|
| Abiomed | None | $164 | 2 payments
|
| Paragonix Technologies | Sherpapak | $44 | 1 payment
|
See all 32 published payments
| Abiomed | Meals · 2025-12-19 | None | $123 |
| Abbott Laboratories | Meals · 2025-12-07 | Thoratec Heartmate 3 Lvas Implant Kit | $163 |
| AtriCure | Meals · 2025-12-03 | Atriclip Laa Exclusion System | $13 |
| Ethicon US | Meals · 2025-11-20 | Prolene | $149 |
| Abbott Laboratories | Consulting · 2025-11-05 | 2nd Gen Centrimag Primary Console | $3,250 |
| Abbott Laboratories | Consulting · 2025-11-05 | 2nd Gen Centrimag Primary Console | $4,550 |
| Edwards Lifesciences | Meals · 2025-10-29 | Sapien 3 Ultra Resilia | $48 |
| Edwards Lifesciences | Meals · 2025-10-27 | Evoque | $72 |
| Edwards Lifesciences | Meals · 2025-10-27 | Sapien 3 Ultra Resilia | $130 |
| Edwards Lifesciences | Meals · 2025-10-24 | Pascal | $185 |
| Edwards Lifesciences | Meals · 2025-10-10 | Sapien 3 Ultra Resilia | $28 |
| Paragonix Technologies | Meals · 2025-10-01 | Sherpapak | $44 |
| Abbott Laboratories | Meals · 2025-09-17 | Thoratec Heartmate 3 Lvas Implant Kit | $37 |
| Abbott Laboratories | Meals · 2025-09-16 | Thoratec Heartmate 3 Lvas Implant Kit | $7 |
| AtriCure | Meals · 2025-09-10 | Synergy Ablation System | $52 |
| Ethicon US | Meals · 2025-08-14 | Vistaseal | $23 |
| Ethicon US | Meals · 2025-07-18 | Prolene | $12 |
| Edwards Lifesciences | Meals · 2025-07-11 | Sapien 3 Ultra Resilia | $27 |
| Edwards Lifesciences | Meals · 2025-07-03 | Pascal | $32 |
| Edwards Lifesciences | Meals · 2025-06-11 | Sapien 3 Ultra Resilia | $32 |
| Abbott Laboratories | Travel · 2025-05-29 | Cardiomems | $229 |
| Abbott Laboratories | Travel · 2025-05-29 | Cardiomems | $229 |
| Abbott Laboratories | Travel · 2025-05-29 | Cardiomems | $9 |
| Abbott Laboratories | Meals · 2025-05-19 | Thoratec Heartmate 3 Lvas Implant Kit | $148 |
| Abbott Laboratories | Meals · 2025-05-15 | Thoratec Heartmate 3 Lvas Implant Kit | $139 |
| AtriCure | Meals · 2025-05-14 | Atriclip Laa Exclusion System | $47 |
| Abbott Laboratories | Consulting · 2025-04-29 | Thoratec Heartmate 3 Lvas Implant Kit | $975 |
| Abiomed | Meals · 2025-04-12 | None | $40 |
| AtriCure | Meals · 2025-03-19 | Atriclip Laa Exclusion System | $49 |
| Edwards Lifesciences | Meals · 2025-03-10 | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $23 |
| Ethicon US | Meals · 2025-02-10 | Prolene | $13 |
| AtriCure | Meals · 2025-01-27 | Atricure Cryoice Cryoablation System (Cryo2) | $15 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $6,552
| Abbott Laboratories | Thoratec Heartmate 3 Lvas Implant Kit | $5,494 | 12 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $788 | 9 payments
|
| Abiomed | Impella | $270 | 3 payments
|
2023: $5,545
| Abbott Laboratories | Thoratec Heartmate 3 Lvas Implant Kit | $5,211 | 7 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $171 | 4 payments
|
| Abiomed | Impella | $163 | 2 payments
|
2022: $6,550
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $4,374 | 19 payments
|
| Abbott Laboratories | Thoratec Heartmate 3 Lvas Implant Kit | $1,857 | 14 payments
|
| AtriCure | Synergy Ablation System | $306 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $13 | 1 payment
|
2021: $3,146
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $1,671 | 2 payments
|
| Medtronic | Corevalve Evolut | $774 | 10 payments
|
| Abbott Laboratories | Heartmate 3 Left Ventricular Assist Device | $682 | 10 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $18 | 1 payment
|
2020: $12,953
| Abbott Laboratories | Heartmate 3 Left Ventricular Dev | $12,839 | 20 payments
|
| Edwards Lifesciences | Inspiris Resilia Aortic Valve | $93 | 3 payments
|
| CathWorks | Ffrangio System | $22 | 1 payment
|
2019: $26,773
| Abbott Laboratories | Heartmate 3 Left Ventricular Dev | $25,762 | 23 payments
|
| Medtronic Vascular | Corevalve Evolut | $455 | 4 payments
|
| Edwards Lifesciences | Inspiris Resilia Aortic Valve | $199 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $121 | 1 payment
|
| LivaNova USA | Tandemlung | $120 | 1 payment
|
| HeartFlow | None | $55 | 1 payment
|
| Abiomed | Impella | $45 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $15 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Abbott Laboratories · Multi-Center Study of Maglev Technology in Patients Undergoing Mcs Therapy With Heartmate 3 Continued Access Protocol · 2019 | Their institution | $104,098 |
| Abbott Laboratories · Momentum 3 Cap Multi-Center Study of Maglev Technology in Patients Undergoing Mcs Therapy With Heartmate 3 Continued Access Protocol · 2020 | Their institution | $24,328 |
| Abbott Laboratories · Antiplatelet Removal and Hemocompatibility Events in the Heartmate 3 Pump · 2020 | Their institution | $13,680 |
| Abbott Laboratories · Antiplatelet Removal and Hemocompatibility Events in the Heartmate 3 Pump · 2021 | Their institution | $12,851 |
| Abbott Laboratories · Antiplatelet Removal and Hemocompatibility Events in the Heartmate 3 Pump · 2022 | Their institution | $7,803 |
| Abbott Laboratories · Multi-Center Study of Maglev Technology in Patients Undergoing Mcs Therapy With Heartmate 3 Continued Access Protocol · 2021 | Their institution | $7,516 |
| Abbott Laboratories · Antiplatelet Removal and Hemocompatibility Events With the Heartmate 3 Pump Ide Study (Aries) · 2023 | Their institution | $4,903 |
| Abbott Laboratories · Momentum 3 Pivotal Cohort Extended Follow-Up Post-Approval Study · 2020 | Their institution | $2,552 |
| Abbott Laboratories · Momentum 3 Pivotal Cohort Extended Follow-Up Post-Approval Study · 2022 | Their institution | $2,050 |
| Abbott Laboratories · Momentum 3 Extended Follow-Up Post Approval Study · 2021 | Their institution | $1,670 |
| Abbott Laboratories · Momentum 3 Extended Follow-Up Post Approval Study · 2019 | Their institution | $1,614 |
| Abbott Laboratories · Multi-Center Study of Maglev Technology in Patients Undergoing Mcs Therapy With Heartmate 3 · 2019 | Their institution | $294 |
| Abbott Laboratories · Hm3 Swift Study · 2019 | Their institution | $50 |
Professional record
- NPI
- 1710072988
- Licence
- CA A79567, NC 200200801California A79567: Current · expires 2027-08-31
- Trained
- Baylor College of Medicine, 1992 · 34 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Thoracic surgery (208G00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-10-04
- NPI last updated
- 2020-05-29
- NPI record certified
- 2020-05-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2340 Clay St, San Francisco, CA, 94115